- Home
- CDRE vs BSX Comparison
CDRE vs BSX Comparison
Compare CDRE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- BSX
- Stock Information
- Founded
- CDRE 2012
- BSX 1979
- Country
- CDRE United States
- BSX United States
- Employees
- CDRE N/A
- BSX N/A
- Industry
- CDRE Industrial Specialties
- BSX Medical/Dental Instruments
- Sector
- CDRE Health Care
- BSX Health Care
- Exchange
- CDRE Nasdaq
- BSX Nasdaq
- Market Cap
- CDRE N/A
- BSX 138.5B
- IPO Year
- CDRE 2021
- BSX 1992
- Fundamental
- Price
- CDRE $30.74
- BSX $95.12
- Analyst Decision
- CDRE Strong Buy
- BSX Strong Buy
- Analyst Count
- CDRE 1
- BSX 23
- Target Price
- CDRE $37.00
- BSX $107.61
- AVG Volume (30 Days)
- CDRE 263.0K
- BSX 10.1M
- Earning Date
- CDRE 05-06-2025
- BSX 04-23-2025
- Dividend Yield
- CDRE 1.24%
- BSX N/A
- EPS Growth
- CDRE N/A
- BSX 16.82
- EPS
- CDRE 0.90
- BSX 1.25
- Revenue
- CDRE $567,561,000.00
- BSX $16,747,000,000.00
- Revenue This Year
- CDRE $8.19
- BSX $15.60
- Revenue Next Year
- CDRE $8.18
- BSX $10.28
- P/E Ratio
- CDRE $34.16
- BSX $76.10
- Revenue Growth
- CDRE 17.62
- BSX 17.61
- 52 Week Low
- CDRE $27.07
- BSX $66.80
- 52 Week High
- CDRE $40.28
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- CDRE 48.36
- BSX 45.80
- Support Level
- CDRE $27.96
- BSX $86.77
- Resistance Level
- CDRE $31.81
- BSX $96.69
- Average True Range (ATR)
- CDRE 1.35
- BSX 4.05
- MACD
- CDRE 0.33
- BSX -0.02
- Stochastic Oscillator
- CDRE 77.41
- BSX 59.74
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.